These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28847023)

  • 1. Saliva versus Plasma Bioequivalence of Valsartan/Hydrochlorothiazide in Humans: Validation of Classes II and IV Drugs of the Salivary Excretion Classification System.
    Idkaidek N; Agha H; Arafat T
    Drug Res (Stuttg); 2018 Jan; 68(1):54-59. PubMed ID: 28847023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saliva Versus Plasma Bioequivalence of Azithromycin in Humans: Validation of Class I Drugs of the Salivary Excretion Classification System.
    Idkaidek N; Arafat T; Hamadi H; Hamadi S; Al-Adham I
    Drugs R D; 2017 Mar; 17(1):219-224. PubMed ID: 28074334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva vs. plasma bioequivalence of paracetamol in humans: validation of class I drugs of the salivary excretion classification system.
    Idkaidek N; Arafat T
    Drug Res (Stuttg); 2014 Oct; 64(10):559-62. PubMed ID: 24452519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva versus plasma bioequivalence of rusovastatin in humans: validation of class III drugs of the salivary excretion classification system.
    Idkaidek N; Arafat T
    Drugs R D; 2015 Mar; 15(1):79-83. PubMed ID: 25666686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva vs. plasma bioequivalence of metformin in humans: validation of class II drugs of the salivary excretion classification system.
    Idkaidek N; Arafat T
    Drug Res (Stuttg); 2014 Nov; 64(11):599-602. PubMed ID: 24452520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saliva versus Plasma Relative Bioavailability of Tolterodine in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System.
    Idkaidek N; Najib N; Salem II; Najib O
    Drug Res (Stuttg); 2016 Jun; 66(6):312-5. PubMed ID: 27011385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system.
    Idkaidek N; Arafat T
    Mol Pharm; 2012 Aug; 9(8):2358-63. PubMed ID: 22784220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Troubleshooting of bioinequivalence of compound valsartan tablets].
    Shao D; Zhang YF; Zhan Y; Chen XY; Zhong DF
    Yao Xue Xue Bao; 2014 Apr; 49(4):524-9. PubMed ID: 24974472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
    Hedaya MA; Helmy SA
    Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of food on the oral bioavailability of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide fixed dose combination tablets in healthy subjects.
    Sunkara G; Jiang X; Reynolds C; Serra D; Zhang Y; Ligueros-Saylan M; Ayalasomayajula S; Winter S; Jarugula V
    Clin Pharmacol Drug Dev; 2014 Nov; 3(6):487-92. PubMed ID: 27129123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence evaluation of a triamterene-hydrochlorothiazide generic product: a new bioequivalence index for fixed-dose combinations.
    Hamidi M; Shahbazi MA; Azimi K
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):149-56. PubMed ID: 21193005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bioavailability of two irbesartan/hydrochlorothiazide tablet formulations in Indonesian healthy subjects.
    Sasongko L; Harahap Y; Prasaja B; Lusthom W; Setiawan EC; Meliala RS; Lipin
    Arzneimittelforschung; 2010; 60(12):749-53. PubMed ID: 21265466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the bioequivalence of two tablet formulations of enalapril/hydrochlorothiazide after single oral administration to healthy volunteers.
    Niopas I; Daftsios AC; Nikolaidis N
    Arzneimittelforschung; 2004; 54(3):160-5. PubMed ID: 15112862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic properties and bioequivalence of olmesartan medoxomil/hydrochlorothiazide in healthy Korean male subjects.
    Jin C; Jeon JY; Im YJ; Jung JA; Kim Y; Park K; Choi Y; Chae SW; Kim MG
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):64-72. PubMed ID: 24290413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hydrochlorothiazide and amlodipine on single oral dose pharmacokinetics of valsartan in healthy Korean subjects: Population model-based approach.
    Ngo L; Cho HY; Lee YB
    Eur J Pharm Sci; 2018 Jun; 118():154-164. PubMed ID: 29604332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence study of 2 formulations of film-coated tablets containing a fixed dose combination of bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg in healthy subjects.
    Tjandrawinata RR; Setiawati E; Yunaidi DA; Santoso ID; Setiawati A; Susanto LW
    Drug Res (Stuttg); 2013 May; 63(5):243-9. PubMed ID: 23539427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
    Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of saliva and plasma for drug bioavailability and bioequivalence studies in humans.
    Idkaidek NM
    Saudi Pharm J; 2017 Jul; 25(5):671-675. PubMed ID: 28725138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.